These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 743858)

  • 1. [Hypoglycemic agents of the 2d generation].
    Giulietti M
    Clin Ter; 1978 Jul; 86(2):179-81. PubMed ID: 743858
    [No Abstract]   [Full Text] [Related]  

  • 2. [Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1990; ():325-34. PubMed ID: 2195215
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term effect of gliclazide on platelet function in diabetes].
    Pan CY
    Zhonghua Yi Xue Za Zhi; 1984 Apr; 64(4):233-5. PubMed ID: 6432285
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemorheologic, metabolic and blood coagulation changes in diabetics in treatment with sulfanyl ureas].
    Cortinovis A; Crippa A; Sciacca V; Caravaggio V; Crippa M
    Minerva Med; 1988 May; 79(5):391-8. PubMed ID: 3131696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis].
    Voss D; Fuchs G; Schneider D; Schneider J
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2219. PubMed ID: 4679252
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with diamicron treatment of diabetics].
    Velikov VK; Shubina IO; Saltykov BB; Frolova AI
    Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.
    Paton RC; Kernoff PB; Wales JK; McNicol GP
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1018-20. PubMed ID: 6794745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does hypoglycemic treatment with gliclazide and gliquidone affect platelet function in type II diabetic patients?].
    Strojek K; Bresler M; Gumprecht J; Grzeszczak W; Trautsolt W
    Pol Arch Med Wewn; 1993 Apr; 89(4):315-9. PubMed ID: 8351232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypoglycemic and microvascular properties of gliclazide: a review of the latest international studies].
    Lesobre B
    Sem Hop; 1983 Jun; 59(24):1827-33. PubMed ID: 6308816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Masbernard A; Portal A
    Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of gliclazide on prostaglandin I2 formation in normal and streptozotocin-induced diabetic animals.
    Fujitani B; Maeda J; Tsuboi T; Kadokawa T; Shimizu M
    Jpn J Pharmacol; 1983 Oct; 33(5):965-70. PubMed ID: 6358588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.
    Holmes B; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Apr; 27(4):301-27. PubMed ID: 6373223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliclazide: the effects on lipids in type II diabetes.
    Delargy M; McGovern M; Johnson A; Tomkin GH
    Ir J Med Sci; 1985 Mar; 154(3):102-5. PubMed ID: 3997441
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of gliclazide on platelet function in patients with diabetes mellitus.
    Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
    Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology of S-1702. Its action on glycemia and the microvascular system of normal and diabetic animals].
    Duhault J; Lebon F; Boulanger M
    Journ Annu Diabetol Hotel Dieu; 1971 May; 12(0):257-60. PubMed ID: 5164767
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of diamicron on various blood coagulation indices in patients with type II diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Novikova NV; Nepsha VD
    Klin Med (Mosk); 1983 Apr; 61(4):66-8. PubMed ID: 6865293
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of insulin and sulfonylurea derivatives on chronic intravascular microcoagulation of the blood in diabetes mellitus].
    Velikov VK; Galkina AK; Bokarev IN; Frolova AI; Shubina OI
    Sov Med; 1985; (9):91-3. PubMed ID: 3906934
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro effect of glysolamide on blood coagulation].
    Dalla Vedova R; Cadel S; Wassermann A
    Boll Chim Farm; 1979 Jan; 118(1):28-30. PubMed ID: 454528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.